Creating an innovation economy in

12 February 2015

Presented by

Mr. Philip Yeo

Chairman, Standards, Productivity and Innovation for Growth SPRING, www.spring.gov.sg

Chairman, Economic Development Innovations Singapore EDIS, www.edis.sg Singapore’s Economy Today

Total Value 2013 GDP: US$295.1 bil* Output Added Financial Others Services Construction 34% 7% 6% Chemicals 4% 12% Other Services Electronics 28% 30% 18% 19% Manufacturing

Precision 11% 13% Transport & Engineering Storage 7% Transport 11% 17% Engineering 16% Business Services Biomedical Wholesale & 18% Sciences 8% 21% Retail Trade General 8% 12%

* 2 January 2015 –MTI press release indicates GDP for 2014 is estimated to have grown by 2.8 per cent (Manufacturing by 2.4 per cent) 50 Years of Economic Development Singapore: A Vibrant Business Hub ►7,000 Multinational Corporations 60% with global or regional headquarters.

► 37,400 Ease of Doing Business Strong IP Protection Best Labour Force International Companies Including 3,200 from China, 4,400 from India, and 7,900 from Rank Country Rank Country Singapore 89 ASEAN. United States 76 1Singapore 1Sweden Taiwan 75 Switzerland 75 2Hong Kong 2 Finland Belgium 73 3New Zealand 3Singapore Japan 73 ► 116,000 Ireland 66 4United States 4 Luxembourg Sweden 66 Small & Medium Enterprises 5Denmark 5Austria Netherlands 65 1,000 identified with the goal of Australia 65 growing revenues to S$100 Source: World Bank’s “Ease of Source: The Global Source: BERI’s 2010 Labour Doing Business” Index 2011 Competitiveness Report million. (2010,2011), World Economic Force Evaluation Forum Source: Accounting & Corporate Regulatory Authority, 2Q 2010.

3 Phases of Economic Development

Jobs & Innovation GDP Growth Intensive Technology Intensive 2000s

Capital Knowledge‐based Intensive 1990s Economy Skill Cluster Developments: Intensive 1980s One‐North Key Game Changer Development Labour Creating Business 200 hectares Jurong Island Intensive Parks: Twin Engine 2000‐20 Master Plan 1970s of Manufacturing Petrochemical Industrial estates and Services Complex with amenities at Singapore Science 1960s the fringe of Parks residential towns The First Industrial Township Flatted Factories Jurong Industrial Estate Our Approach: Industry Development

We have no markets, no raw materials. All the industry we’ve created is illogical. But what choice do we have?

ELECTRONICS CHEMICALS

• 40% of world’s hard disk media production • 14 silicon wafer fabrication plants • 20 semiconductor assembly & test operations • 40 IC design centres

PRECISION BIOMEDICAL SCIENCES ENGINEERING

• Largest & most comprehensive aerospace maintenance, repair & overhaul centre in Asia • 70% of world’s production of jack‐up oil rigs and FPSO conversion; 20% of world’s ship repair market Industrial Development: Biomedical Sciences

Manufacturing Output* S$22.9 billion (US$18.3 billion)

Manufacturing mil Employment S$ 16,704 employees

Value‐Added* S$11.8 billion (US$ 9.4 billion)

GDP Share (2013): 3.81% Launch of Opening Total Employment: >20,000 BMS Initiative of Biopolis CAGR (2013): 10%

Compounded Annual Growth Rates (CAGR) computed over 5 years *Value‐Add = Labour Cost + Depreciation + Interest Cost + Profit before Tax + Land Cost Pharma Manufacturing Plants Industrial Development: Biomedical Sciences Pharmaceutical Manufacturing Plants Tuas Biomedical Park

Bulk API and secondary Bulk biologics Microbial and mammalian manufacturing plants manufacturing plant bulk biologics facility 1 Cell Therapy Facility 3

Bulk API plants with Tablet facility Bulk nutritionals pilot facility and Biologics Manufacturing plant pediatric vaccines Facility 2 plant

Bulk API and Biologics and Bulk API nutritionals recombinant intermediates Vaccines plant plant therapies plant plant

Biologics plant Biologics and API plant

Quality & Operational Excellence ‐ Zero major observations with regulators Manufacturing for the world ‐ Track record producing for global markets ‐29 commercial scale manufacturing facilities ‐ Strong global logistics ‐7 of the top 10 Big Pharma ‐ Secure business environment ‐API, biologics, cell therapy, nutrition ‐ Access to talent Industrial Development: Biomedical Sciences BioMedical Sciences (BMS) Initiative

PHARMACEUTICALS MEDICAL TECHNOLOGY Development of Bioimaging Medical devices, small molecule Bioprocessing info tech, diagnostics therapeutics Genomics & Proteomics Molecular & Cell Biology Drug/Biologics Discovery and Development Bioengineering & Nanotechnology Computational Biology

Development of Immunology INDUSTRY INDUSTRY high‐value nutrition Skin Biology Development of and personal care / Nutritional Sciences protein‐based consumer products Metabolic Disease therapeutics NUTRITION & BIOTECHNOLOGY PERSONAL CARE & BIOLOGICS BIOMEDICAL SCIENCES DIRECTION BENCH BEDSIDE

Basic Translational Clinical Service Delivery

Ministry of Health Public Sector Healthcare Groups Research Institutes Institute of Medical Biology •Ethical regulations/framework for •Skin Basic & Translational biology clinical research, e.g. IRBs • Institute of Molecular & Cell • Genetic Diseases 1. Singapore Health Services •HSA – Evaluation capabilities for new Biology • Regenerative Medicine (including • Singapore General Hospital technologies stem cells) •KK Women and Children’s Hospital •Genome Institute of • National Cancer Centre Singapore Experimental Therapeutics National Medical Research Council • National Dental Centre • Clinical research strategy • National Heart Centre Centre •Grant management • National Neuroscience Institute • Institute of Bioengineering & •Drug Discovery & Development • Manpower development 2. National Healthcare Group Nanotechnology from target validation to early • Getting research outcomes into phase clinical trials • Tan Tock Seng Hospital • Bioprocessing Technology usage in patient care • Institute of Mental Health Institute • National Skin Centre • Communicable Disease Centre • Bioinformatics Institute Hospital Institutions 3. National University Health System Consortia 1. Tertiary Centres • National University Hospital • Singapore BioImaging Consortium •NUS School of Medicine • National University Hospital • National University Cancer Institute • Singapore Immunology Network • National University Cancer Institute • National University Heart Centre • Singapore Stem Cell Consortium •NUS Cancer Science Institute • National University Heart Centre (now subsumed into IMB) 4. Alexandra Health •Khoo Teck Phuat Hospital •Duke‐NUS Graduate Medical Outram Campus 5. Jurong Health • Singapore General Hospital School • Alexandra Hospital Singapore Institute for Clinical • National Cancer Centre Sciences • National Heart Centre •Ng Teng Fong General Hospital • Develop programmes in • National Neuroscience Institute 6. Eastern Health Alliance translational & clinical medicine • Singapore National Eye Centre • Changi General Hospital •Focus on Growth, Development & •Duke‐NUS Graduate Medical School Metabolism Private Sector Healthcare Groups • Develop Clinician Scientists 2. Others with specific capabilities • Parkway Group •KK Women and Children’s Hospital • Raffles Medical Group •Thomson Medical •Tan Tock Seng Hospital 9 Building Biomedical R&D Capabilities

Phase 1: 2000 – 2005 Phase 2: 2006 – 2010 Developing Basic Translational & Science Capabilities Clinical Research Other BMRC labs and joint initiatives:

Institute of p53 Laboratory Bioengineering & Singapore Institute Molecular Nanotechnology for Clinical Engineering Sciences Laboratory Genome Singapore Institute of Bioimaging Singapore Consortium Experimental Translational Therapeutics Centre Laboratory in Genetic Medicine Bioprocessing Singapore Technology Immunology Institute of Institute Network Molecular & Cell Bioinformatics Institute of Biology Institute Medical Biology Clinical Imaging Research Centre

Before 20002001 2003 2005 2006 2007 2011 2000 Phase 3: 2011‐2015 Integrating for Impact BMS Phase 1: Developing Basic Research Capabilities

World Class Expertise World Class Infrastructure World Class Talent Core technologies and expertise Biopolis: 4M sq ft integrated Pioneers and thought leaders in areas including genomics research campus from around the globe analysis, animal disease models, stem cells, drug screening, construction and mass production of monoclonal antibodies, bioimaging

Institute of Molecular & Singapore Cell Biology Stem Cell Singapore Institute Consortium for Clinical Sciences

Institute of Experimental Bioengineering & Therapeutics Nanotechnology Centre

Genome Singapore Bioprocessing Institute of Bioimaging Institute of Technology Singapore Bioinformatics Consortium Medical Biology Institute Institute

Pre‐2000 20002001 2002 2003 2004 2005 2006 2007 onwards11 BMS Phase 2: Translational & Clinical Research (TCR) Efforts

Basic Translational and Clinical Phase I, II & III Medical Research Research (TCR) Clinical Trials Applications

Initiatives to promote TCR Supporting Infrastructure

1 (TCR) Flagship Programme • Investigational Medicine Units •5 strategic disease‐orientated areas • Singapore Clinical •Each awarded S$25mil over 5 years Research Institute Cancer Metabolic Disease Eye Disease • Clinical Imaging Neuroscience Infectious Diseases Research Centre

Talent Attraction / Development

Developing a pipeline of 2 Bedside & Bench Grant Call Clinician Scientists •Foster collaboration between basic •S'pore Translational Research scientists and clinical investigators Investigator Award (STaR) • Funded for up to 3 years • Clinician Scientist Award (CSA) BMS Phase 3: Integrating for Impact

Basic Translational Economic and Health Discovery Clinical Research Outcomes

Industry Research Engagement Excellence Clinical Commercialisation Scientific Collaboratio & Capabilities ns Spin‐offs

BMRC Technology Platforms

Constant Pipeline of Talent Other Innovations: Global Hydrohub

Global Hydrohub Impetus to seek 150 water companies Resource‐constrained alternative water sources Struggled with water needs & explore advanced water technologies to be self‐ sufficient

Establishment of Environment & Water Research Centres to support Industry Programme needs of the stakeholders Office Focus • Attract major international water companies – anchor R&D, engineering, manufacturing and HQ Environmental & water technology operations in Singapore research • Encourage companies and research institutes to develop test‐beds and Incentives to drive development commercialise cutting‐edge water of innovative water solutions technology • Export technologies globally R&D grants in municipal and • Groom Singapore‐based water industrial water treatment solutions companies to be international players Other Innovations: Smart Sustainable Buildings Vision: To realise Smart Sustainable Buildings of the future, today. Pre‐Project Innovation Consortium ‐ World’s first integrative design platform launched in Singapore to accelerate innovation in building industry

Research Construction Zero‐carbon Energy Efficiency areas: productivity buildings Other Innovations: Safe City Test Bed Develop a Safety and Security industry with strong innovation capacity through public‐private partnerships Jointly driven by the Economic Development Board and the Ministry of Home Affairs 1 Pooling of agencies’ data sets together into The a IDEA “black box”

2 If a trigger is reached, an alert will be routed to the relevant agency

Trigger can be pre‐determined or based on machine‐learning

Test‐bedding of Solutions based on Consortia developed new Safe City information‐sharing 4 industry consortia and tested solutions technologies in model developed by selected to based on agencies’ multiple locations in selected government participate challenges Singapore agencies Fostering Innovation & Enterprise: An Integrated Strategy

A Strong Ecosystem of Stakeholders Innovation through planning and policies

Research, Innovation & Science & Technology Enterprise Plan 2015 Plan 2010 (2011 – 2015) Science & Technology (2006 – 2010) S$16.1 b Plan 2005 S$13.9 b (2001 – 2005) National Science & S$6 b Technology Plan (1996 – 2000) S$4 b * National ‐ Focus on R&D with Technology Plan ‐ Make targeted R&D investments economic outcomes (1991 – 1995) ‐ Invest in S$2 b in areas of ‐ Foster public‐private public‐sector partnerships ‐ Deepen long‐ BMS research competitive term S&T advantage ‐ Increase support for ‐ Build critical commercialisation capabilities mass of private‐ ‐ Intensify efforts ‐ Encourage sector BMS to engage private Spur R&D private sector R&D activities sector in R&D 1st steps to align growth to R&D public RIE investments enhance investment with industry needs economic and economic value competitiveness capture Economic outcomes key focus since NTP 1991–1995* Research, Innovation & Enterprise 2015

“Singapore’s long term aim is to be among the most research intensive, innovative and entrepreneurial economies in the world in order to create high value jobs and prosperity for Singaporeans.

Research and innovation underpin the competitiveness of our industries, catalyse new growth areas, and transform our economy. Prime Minister Mr. Increasingly, intellectual capital will be critical for our next phase of economic development. Hence, the government will allocate 4th RIEC Meeting S$16.1 billion [~1% of GDP] to support research, innovation and 17th Sept 2010 enterprise activities in the next 5 years.”

Information on this slide is confidential and strictly for use by SPRING Singapore officers only. It should not be used or referred to by third parties without prior written consent from SPRING Singapore. RIE 2015 Innovation & Enterprise Strategies

RIE2015 signaled an increase in focus on I&E as a key pillar of Singapore’s R&D strategy

Innovation and enterprise strategies aimed to cover the entire value chain from technology development to pre‐IPO, targeted primarily at technology enterprises in manufacturing & other export‐oriented sectors.

Innovation Strategies Enterprise Strategies Enhance Develop Tech Encourage Develop IP Translational Enterprise Entrepreneur‐ Ecosystem Capacity Sector ship

Technology Early Prototype SEEDS Growth Pre‐IPO Development Stage Overview of 2015 Programmes

Enhancing Translational Capacity Developing IP Ecosystem

•Proof‐of‐Concept (POC) Grants •Technology Transfer Office (TTO) Funding •ETPL Gap Funding •A*STAR •NRF POC •Autonomous Universities New •Innovation Grant to IHLs •Hospitals New •MOE Translational R&D and Innovation Fund New •IP Portal and Intermediary •Centres of Innovation (COIs) •IPI Pte Ltd New •Centres of Innovation •Private Sector Translation Services •Private Sector Translators New

Developing the Technology Enterprise Sector Encouraging Entrepreneurship •Early stage technology start‐ups •Global Entrepreneurial Executives (GEE) Scheme •Technology Incubation Scheme • •Early Stage Venture Funds Entrepreneurship Education Fund for Universities •Overseas spinoffs from MNCs or foreign SMEs •Innovation & Entrepreneurship Institute •Technology Commercialization Scheme New •Sector Specific Accelerators •Biomedical Sector Accelerator New •Secondment of Researchers to Industry •A*STAR •Polytechnics New Highlights ‐ Centres of Innovation (COIs) Offer technology consultancy and facilities to develop technology projects and solutions

> 1,600 projects, 3000 SMEs supported (cumulative) Innovation Capital

BMS Licensing Licensing Revenue 60 56 1200 52 1060 50 1000 884 38 40 800 684 596 30 600 22 21 334 20 400 11 200 120 10 7 70 62 5 3 554 0 0 2006 2007 2008 2009 2010 2011 2012 2013

BMS Start‐ups Trend of Patent Filing vs Patent Utilization Rate 120 6 108 55 100 5 100 Number of 4 Patents 80 74 73 4 67 70 Filed 3 3 3 60 49 53 2 46 Patents 2 Licensed 40 30 34 1 11 1 1 21 1 16 20 10 10 0 5 0 0 2006 2007 2008 2009 2010 2011 2012 2013 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 Human Capital

5000 Private Sector Public 4500 Agencies

4000

3500 10.9 % growth 3000 RSEs 2500 of

2000 No.

1500 16.8 % growth 1000

500

0 2000 2012 2000 2012 Bachelor Master PhD

Source: National R&D survey 2012 Building Up R&D Human Capital

Research Scientists & Engineers (RSEs) grew from 4,300 to 30,100 (between 1990‐2012) RSEs in the private sector grew more than tenfold from 1,360 to 16,500 35000

30000

25000

20000 Public Sector RSEs 15000 Private Sector RSEs

10000

5000

0 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012

Manpower Growth Public Private Total 55% of total RSEs work in the CAGR 1990-2012(PhD) 9.6% 15.8% 10.3% private sector CAGR 1990-2012 (Overall) 7.2% 12.0% 9.2%

Source: National R&D Survey of Singapore A*STAR’S SCIENTIFIC LEADERSHIP Building up Human Capital: Catch a few Whales Senior Scientific Leaders to help develop local talent

(First Row: L to R) – Dr Sydney Brenner, SENIOR FELLOW; Sir David Lane, CHIEF SCIENTIST; Sir George Radda, CHMN, BMRC; Sir John O'Reilly, CHMN, SERC; Prof Edward Holmes, DY CHMN, BMRC; Prof Judith Swain, SENIOR FELLOW; Dr Tan Geok Leng, ED SERC; Dr Benjamin Seet, ED BMRC

(Second Row: L to R) ‐ Prof Lam Kong Peng, ED BTI; Prof Birgitte Lane, ED IMB; Prof Jackie Ying, ED IBN; Prof Ng Huck Hui, ED GIS; Prof Hong Wanjin, ED IMCB; Prof Laurent Rénia, ED SIgN, Prof Alex Matter CEO ETC; A/P Chong Yap Seng, Ag ED, SICS; Prof Patrick Cozzone ED SBIC

(Third Row: L to R) – Prof Kwong Dim Lee, ED IME ; Dr Thomas Liew, ED NMC; Dr Lim Ser Yong, ED SIMTech; Dr Keith Carpenter, ED ICES; Dr Pantelis Alexopoulous, ED DSI; Prof Andy Hor, ED IMRE; Prof Alfred Huan, ED, IHPC; Dr Lee Shiang Long, ED I2R Local Human Capital –Grow PhD Guppies

Guppy – 0.03 meters 1,300 new Singaporean PhDs@ One‐North

Stanford Cambridge Developmental Cambridge Chemistry Biology Medicine/PhD PhD PhD

Imperial College Cambridge Chemistry Natural Science BSc Biology BSc

NUS NTU Stanford Imperial College London Harvard Biomedical Sciences Biological Sciences Genetiics Cancer Biology Stem cells PhD BSc PhD PhD Post‐Doc Human Capital: International Guppies

MIT Stanford MIT Materials Science Chemical Engineering Bio Engineering & Engineering (Shanghai) (Hong Kong) (Malaysia)

Stanford MIT Electrical Engineering Chemical Engineering (India) (Vietnam) Evelyn Thangaraj 2005 A*STAR YRAP Scholar from India Long Term Human Capital Pipeline (currently A*STAR Scholar, MBBS‐PhD, Imperial College, London)

Le Ngoc Phuong Lan

2005 A*STAR YRAP Scholar from Vietnam (currently A*STAR Young Whales

Scholar, PhD Senior Guppies

Biochemistry, University Guppies of Oxford)

10‐14 yrs15‐18 yrs 19‐23 yrs 24‐30 yrs < 35 yrs A*STAR NSS(PhD) AIF Youth Science NSS(BS) AGS AGS Science Awards & AUS SINGA (Post‐doc) YRAP

A*STAR ‐ Agency for Science & Technology Research AGS ‐ A*STAR Graduate Scholarship YRAP ‐ Young Researchers Attachment Programme SINGA ‐ Singapore International Graduate Award NSS ‐ National Science Scholarship AIF ‐ A*STAR International Fellowship AUS ‐ A*STAR Undergraduate Scholarship Nurturing a Talent Pipeline of 1,300 Singaporean PhDs

Awarded more than 1,300 PhD Scholarships to develop Singaporean R&D talent since 2001 More than 460 scholars have completed their PhDs and are contributing to Singapore’s Research, Innovation and Enterprise (RIE) environment

Dr Karen Crasta Dr Jonathan Loh Yuin Han Assoc Prof, Lee Kong Chian School of Principal Investigator, Institute of Medicine, Nanyang Technological University Molecular & Cell Biology (IMCB) A*STAR International Fellow A*STAR Graduate Scholar NRF Fellow 2013

Dr Cheok Chit Fang Principal Investigator, IFOM‐p53 Lab National Science Scholar (PhD)

Dr Seah Kwang Hwee Dr Melissa Fullwood Associate Patent Examiner, Intellectual Assistant Professor, Yale‐NUS College Property Office of Singapore (IPOS) Junior Principal Investigator, Cancer Science A*STAR Graduate Scholar Institute Joint Principal Investigator, Institute for Molecular and Cell Biology National Science Scholar (BS‐PhD) NRF Fellow 2013 Scientific Career Development Scholars Contributing to Public R&D

Joel Yang Young Scientific Leaders Heading Research Labs NSS (PhD) 2004

Jonathan Loh Scientist III, IMRE AGS (NUS) 2003 Asst Prof, Engineering Principal Product Devt, Investigator, SUTD IMCB • 2009 A*STAR Cheok Chit Fang Ho Ying Swan Investigatorship Tan Hwee Pink NSS (PhD) 2001 NSS (PhD) 2002 • 2012 TR35 @ Singapore International • 2010 A*STAR Investigatorship • 2010 R&D 100 Awards Fellowship 2005 • 2010 S’pore Youth Award for S&T Principal Staff Scientist, BTI • 2012 Young Scientist Award, • 2009 Young Scientist Award Investigator, IFOM • Set up & leads Singapore Programme • 2012 TR35 @ Singapore Snr Research Fellow, Manager, I2R Metabolomics Group in BTI p53lab Academic Positions in Local Universities

Melissa Fullwood Juliana Chan NSS (BS) 2002 NSS (BS) 2002 NSS (PhD) 2006 NSS (PhD) 2006

Quek Su Ying Asst Prof, Div of Bioeng, Vincent Tan Asst Prof, Yale‐NUS College Ho Han Kiat NSS (PhD) 2002 School of Chem. & Biomolec. Eng., NTU NSS (PhD) 2006 NSS (PhD) 2000 • 2009 L'Oreal Singapore for Women in Senior Scientist I, IHPC • 2010 S’pore Women’s Weekly Great Asst Prof, Asst Prof, Science National Fellowships Dept of Electrical & • 2010 Postdoctoral Asst Prof, Dept of Physics, Women of Our Time Award (S&T) Dept of Pharmacy, NUS • 2011 L’Oréal For Women in Science Computer Eng, NUS NUS Fellowship, Duke‐NUS GMS • 2010 GE & Science Regional Prize for National Fellowships Young Life Scientists • 2013 NRF Fellowship • 2013 NRF Fellowship • 2014 Young Scientist Award, Singapore Scientific Career Development Scholars Contributing to Industry

Young Entrepreneurs Building up SME Capabilities via T‐Up

Gideon Ho IF 2003 Donny Soh AGS (O) 2005 Chief Commercial Founder, Officer, 9 Degrees HistoIndex Eu Zhi Ang Ryan Chaw AGS (NUS) 2006 Yvonne Koh • Co‐founded HistoIndex, spun • Founder of 9 Degrees, a AGS (NUS) 2003 T‐Up: Hoiio NSS(BS‐PhD) 2002 T‐Up: HVS Eng Pte Ltd off from A*STAR –which spin-off company T‐Up: The Biofactory Pte Ltd • Completed provides stain‐free, 3D, • Developed a device with 3D secondment to Hoiio quantitative imaging motion sensors to collect • Completed secondment to HVS • Currently seconded to Eng., maintenance solutions for • Currently an Associate solutions to visualise & stage data on a player’s tennis Biofactory and working on Patent Examiner at fibrosis stroke or golf swing fluid‐cooled tube & shell heat development of a kit that can exchanger systems IPOS detect a family of disorders • Currently at IPI caused by gene mutations Scientists Contributing Expertise to Industry

Yar Kar Peo Shawn Lim Harmeet Singh Low Yen NSS (PhD) NSS (PhD) AGS (NUS) Ling 2001 2003 Research Scientist, NSS (PhD) Research L’Oreal Research & 2002 Principal Scientist , Innovation Engineer, ST L’Oreal Abbott Electronics Research & Nutrition Tanu Kustandi Natalia Tansil • Worked in I2R Innovation • • Opportunity to work with • Worked in GIS Worked in IMB AGS (NTU) 2003 AGS (NTU) 2004 • Heads digital comms section in • industry while in SICS • Now involved in Now involved in ST Electronics validation of • Seconded, transferred to • Joined Procter & Gamble after collaborations, • Current work: digital comm. technologies / Abbott, working in IMRE such as between aspect of Satellite systems • Health products & diet SIgN and L’oreal, techniques for skin & and with National cosmetic applications52 Skin Center (NSC) Biomedical Research Infrastructure Breaking Ground in Dec 2001: Biopolis Phase 1 one‐north: Biopolis Home for Biomedical Sciences Research

Biopolis Phase 1: Cluster Biopolis Phase 4 (P&G) of 7 Linked Buildings Completed in 2013 Completed in 2004

(under construction) Biopolis Phase 2 Biopolis Phase 5 Completed in 2006 To Complete in 2014

Land Area: 7.5 ha GFA: 350,000 sqm

Biopolis Phase 3 Completed in 2011 Biopolis 1 Biopolis – Phase 1

Helios Matrix Nanos

Genome

Centros Proteos

Chromos one‐north: Fusionopolis Home for Science, Engineering, Infocomm & Media

Land Area: 6.5 ha GFA: 400,000 sqm

Fusionopolis Phase 3 Fusionopolis Phase 1 Completed in 2013 Completed in 2008

Fusionopolis(under construction) Phase 2A To Complete in 2015 Fusionopolis Phase 4 (LucasFilm) Completed in 2013

Fusionopolis Phase 2B Fusionopolis Phase 5 Completed in 2010 To Complete in 2014 Fusionopolis Phase 1 Infrastructure and scientific platform to fuse and to synergize the knowledge for different domains, bringing together public and private R&D activities

Serviced Work‐Live Fitness Gym & Pool Apartments Skybridges and Sky Gardens Business and Research Space

Shared Conference Rooms 500‐seat Experimental Performance Theatre

Retail and F&B Podium

one-north MRT Station One‐North Residences International Sharing

• Singapore started to share its town‐planning and industry development expertise with other cities from the 1990s

• The early projects included Batam Industrial Park in Indonesia and Wuxi‐Singapore Industrial Park in Batam Industrial Park in Indonesia China

• Over 900,000 jobs have been created in parks developed outside Singapore

Wuxi‐Singapore Industrial Park in China China‐ Suzhou Industrial Park

Over 500,000 Jobs Created (Source: China Economic Review) Industrial Parks in India Bangalore

77,000 IT Jobs Created

Hyderabad Chennai Vietnam Singapore Industrial Park

th 140,000 Jobs Created Over 4 Parks Groundbreaking of 5 Park in Sep 2013 Over US$6 billion of investments Located in Quang Ngai province, central Vietnam BPO Prime/PITP in Penang, Malaysia

Map of Penang Proposed Sites Business Process Outsourcing Prime (BPO Prime) . Prime commercial area in Multimedia Super‐Corridor (MSC) Penang Cyber City 1 . Gross Development Value: MYR 1.1b (US$ 340 M) . 28k sqm; GFA: 151k sqm . 7‐mins drive to the airport . “BPO anchored” mixed development: Penang International Technology Park (PITP): Development Approach

Approach For PITP

• Job Creation – Job creation will be at the core of Project PITP’s success. The project will generate ~25,000‐ 30,000 high quality jobs which will in turn drive demand for residential and commercial real estate. • Economic Development – The influx of activity to Project PITP will provide a significant boost to Penang International Technology Park Penang’s economy. (PITP) • Focus On Education and Innovation– Attracting . Heart of the “The Greater Penang” market leaders in education and knowledge‐based . Gross Development Value: MYR 10.1b sectors such as ICT and advanced manufacturing will (US$ 3 B) leverage Penang’s existing capabilities in precision engineering and electronics. . 862k sqm; GFA: 1.8m sqm . Next to new 2nd Penang bridge . Integrated “Work‐Learn‐Live‐Play” township model PITP will create a wealth‐generating engine as a sustainable solution to Penang’s economic transformation Technology Park in South America

Urban Masterplan –Project Overview

Public Parks – Protected Area

Public Parks –Amenities

Institutional

Private Protected Areas

Advanced Technological Park 1

Advanced Technological Park 1

Educational

Office 1

Office 2

Retail

Residential

Mixed Use 1

Mixed Use 2 Thank You

Presented by

Mr. Philip Yeo

Chairman, Standards, Productivity and Innovation for Growth SPRING, www.spring.gov.sg

Chairman, Economic Development Innovations Singapore EDIS, www.edis.sg